BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9696135)

  • 1. Defective early T and T-dependent B cell activation in systemic lupus erythematosus.
    Fernández-Gutiérrez B; de Miguel S; Morado C; Hernández-García C; Bañares A; Jover JA
    Lupus; 1998; 7(5):314-22. PubMed ID: 9696135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early lymphocyte activation in elderly humans: impaired T and T-dependent B cell responses.
    Fernández-Gutiérrez B; Jover JA; De Miguel S; Hernández-García C; Vidán MT; Ribera JM; Bañares A; Serra JA
    Exp Gerontol; 1999 Apr; 34(2):217-29. PubMed ID: 10363788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus.
    Portales-Pérez D; González-Amaro R; Abud-Mendoza C; Sánchez-Armáss S
    Lupus; 1997; 6(1):48-56. PubMed ID: 9116719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of CD23 hyperexpression on B cells from patients with rheumatoid arthritis.
    De Miguel S; Galocha B; Jover JA; Bañares A; Hernández-García C; García-Asenjo JA; Fernández-Gutiérrez B
    J Rheumatol; 2001 Jun; 28(6):1222-8. PubMed ID: 11409113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
    Koshy M; Berger D; Crow MK
    J Clin Invest; 1996 Aug; 98(3):826-37. PubMed ID: 8698875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
    Marken J; Muralidharan S; Giltiay NV
    Arthritis Res Ther; 2021 Jan; 23(1):5. PubMed ID: 33407802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
    Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.
    Desai-Mehta A; Lu L; Ramsey-Goldman R; Datta SK
    J Clin Invest; 1996 May; 97(9):2063-73. PubMed ID: 8621796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The classical and alternative pathways of T-lymphocyte activation in patients with systemic lupus erythematosus].
    Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
    Ter Arkh; 1999; 71(5):30-4. PubMed ID: 10399227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical basis of synergy between antigen and T-helper (Th) cell-mediated activation of resting human B cells.
    Chartash EK; Crow MK; Friedman SM
    J Clin Invest; 1989 Nov; 84(5):1410-7. PubMed ID: 2530248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.
    Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J
    Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus.
    Rider V; Jones S; Evans M; Bassiri H; Afsar Z; Abdou NI
    J Rheumatol; 2001 Dec; 28(12):2644-9. PubMed ID: 11764210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin effect on CD69 and CD154 expression by CD4+ cells from systemic lupus erythematosus patients.
    Chavez-Rueda K; Legorreta-Haquet MV; Cervera-Castillo H; Sánchez L; Jara LJ; Zenteno E; Blanco-Favela F
    Clin Exp Rheumatol; 2005; 23(6):769-77. PubMed ID: 16396693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus.
    Harigai M; Hara M; Fukasawa C; Nakazawa S; Kawaguchi Y; Kamatani N; Kashiwazaki S
    Lupus; 1999; 8(3):227-33. PubMed ID: 10342716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of intracellular calcium is the essential signal for the expression of CD40 ligand.
    Nüsslein HG; Frosch KH; Woith W; Lane P; Kalden JR; Manger B
    Eur J Immunol; 1996 Apr; 26(4):846-50. PubMed ID: 8625977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible different mechanisms of B cell activation in systemic lupus erythematosus and rheumatoid arthritis: opposite expression of low-affinity receptors for IgE (CD23) on their peripheral B cells.
    Kumagai S; Ishida H; Iwai K; Tsubata T; Umehara H; Ozaki S; Suginoshita T; Araya S; Imura H
    Clin Exp Immunol; 1989 Dec; 78(3):348-53. PubMed ID: 2532990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibition.
    Katsiari CG; Liossis SN; Dimopoulos AM; Charalambopoulo DV; Mavrikakis M; Sfikakis PP
    Lupus; 2002; 11(6):370-8. PubMed ID: 12139375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus.
    Sierakowski S; Kucharz EJ
    Med Interne; 1988; 26(1):67-73. PubMed ID: 3261032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.